Skip to content

News

News

Sirtex wants medical professionals and patients to understand how our products can help improve clinical outcomes and the quality of life for people with liver cancer. To help achieve this objective, we want to provide medical journalists and health writers with balanced and comprehensive information about our company, our technology and the medical needs we address.

Latest News

Sep 08 2023
Sirtex Medical Announces Collaboration Agreement with Magle Group for
EmboCept® S DSM 50 μm
Read more..

Sep 15 2022
Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil
Read more..

Feb 09 2022
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
Read more..